SPONSOR
University Hospital, Clermont-Ferrand
Total Trials
17
Recruiting
17
Phases
Phase 4, Phase 3
Conditions studied: Pregnant WomenVenous Thromboembolic DiseaseChronic Lymphocytic LeukemiaCLLProgressive Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic LeukemiaRelapsed Chronic Lymphocytic LeukemiaDecision Making, SharedNeuroblastomaEwing Sarcoma
University Hospital, Clermont-Ferrand is a clinical research sponsor with 17 registered studies on ClinicalTrials.gov, of which 17 are actively recruiting participants. Research covers conditions including Pregnant Women, Venous Thromboembolic Disease, Chronic Lymphocytic Leukemia, CLL.
The trial portfolio spans Phase 4, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — University Hospital, Clermont-Ferrand
How many clinical trials has University Hospital, Clermont-Ferrand sponsored?
ClinicalMetric currently tracks 17 clinical trials sponsored by University Hospital, Clermont-Ferrand, of which 17 are actively recruiting participants. These trials cover conditions including Pregnant Women, Venous Thromboembolic Disease, Chronic Lymphocytic Leukemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University Hospital, Clermont-Ferrand research focus on?
University Hospital, Clermont-Ferrand clinical trials span Pregnant Women, Venous Thromboembolic Disease, Chronic Lymphocytic Leukemia, CLL, Progressive Chronic Lymphocytic Leukemia, and additional conditions. The research pipeline includes Phase 4, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University Hospital, Clermont-Ferrand clinical trial?
To participate in a University Hospital, Clermont-Ferrand trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Hospital, Clermont-Ferrand trials with current recruitment status updated daily.
Clinical Trials by University Hospital, Clermont-Ferrand
NCT06575309
Recruiting
THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin
Pregnant Women
NCT05246345
Recruiting
Venetoclax Resistance Landscape in Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia
NCT06052917
Recruiting
DECIdE, Shared DECIsion in hEalth : the Real-life Impact Study
Decision Making, Shared
NCT07141862
Recruiting
Fertility Preservation in Children With Solid Tumors: Detection of Residual Disease by a Sensitive Method
Neuroblastoma
NCT06604494
Recruiting
Rehabilitation Improved by Early Detection of Fisyulas Post (Pharyngo) -Total Laryngectomy by Cytokine Measurement on Drainage Fluid on the Second Post-Operative Day
Cancer, Otorhinolaryngeal
NCT07330856 Phase 4
Recruiting
Evaluation of Treatments for Dry or Productive Cough
Cough
NCT04375280
Recruiting
Evaluation of Impaired Mobility in Chronic Illness Constitution of a Cohort
Joint Osteoarthritis
NCT03083184 Phase 3
Recruiting
Evaluation of the Efficacy of an inTerdialytic "Ethanol 40% v/v - enoxapaRin 1000 U/mL" Lock solutioN to Prevent Tunnelled Catheter Infections in Chronic Hemodialysis Patients
Tunnelled Hemodialysis Catheter Infection
NCT07415837
Recruiting
Evaluation of the Role of miR-1 in the Pathogenesis and as a Biomarker in Muscular Dystrophies and Congenital Myopathies
Duchenne / Becker Muscular Dystrophy
NCT06517342
Recruiting
Motivations, Obstacles and Opportunities for Using a Health Application to Encourage Physical Activity in People With Chronic Low Back Pain
Chronic Low-back Pain
NCT05641142
Recruiting
Prospective Study of Antiplatelet and Anticoagulation Therapy in Hereditary Haemorrhagic Telangiectasia
Hereditary Hemorrhagic Telangiectasia
NCT04959838
Recruiting
JOB STRESS in OPHthalmology Physicians and Residents
Stress
NCT06972901
Recruiting
Evaluation of Therapeutic Strategy to Prevent Crohn's Disease Endoscopic poSToperatIve recurreNce Based on earlY Dosage of Faecal Calprotectin
Crohn Disease (CD)
NCT05931406
Recruiting
Effects of a Sedentary Behaviors at Work on Health in Emergency Medical Dispatchers and CODIS Operators (SECODIS)
Sedentary Behavior
NCT06920524
Recruiting
Interest of a Musical Intervention on Stress Induced During Botulinum Toxin Injections in Spasticity (MUSIBOT)
Stroke
NCT06986980
Recruiting
Intestinal Microsporidiosis in French Heart Transplant Recipients (CARMIC)
Microsporidiosis Intestinal
NCT06807723
Recruiting
Further Delineation of the De Santo Shinawi Syndrome Phenotype Using a Series of Individuals Carrying a Pathogenic Variant of the WAC Gene
WAC
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology